Results 21 to 30 of about 48,842 (275)

Invasive coronary physiology in patients with angina and non-obstructive coronary artery disease: a consensus document from the coronary microvascular dysfunction workstream of the British Heart Foundation/National Institute for Health Research Partnership [PDF]

, 2022
Nearly half of all patients with angina have non-obstructive coronary artery disease (ANOCA); this is an umbrella term comprising heterogeneous vascular disorders, each with disparate pathophysiology and prognosis.
Rahman, H., Hoole, S.P., Channon, K., UK Coronary Microvascular Dysfunction Working Group, Morris, Paul D, Kharbanda, Rajesh K, Divaka Perera, Channon, K, Petraco, Ricardo, Haseeb Rahman, Hoole, SP, Perera, D., Sinha, Aish, Ricardo Petraco, Keith Channon, Colin Berry, Paul D Morris, Channon, Keith, Stephen P Hoole, Morris, P.D., Hoole, Stephen P, Rajesh K Kharbanda, Rahman, Haseeb, Kharbanda, RK, Hoole, Stephen P., Kharbanda, R.K., Aish Sinha, Petraco, R, Kharbanda, Rajesh K., Perera, Divaka, Sinha, A., Morris, Paul D., Berry, Colin, Berry, C, Morris, PD, Berry, C., Perera, D, Sinha, A, Petraco, R., Rahman, H   +39 more
core   +1 more source

INOCA/ANOCA: Mechanisms and novel treatments

American Heart Journal Plus, 2023
Angina or ischemia with no obstructive coronary disease (ANOCA/INOCA) is a common but under-treated condition due to poorly understood pathophysiologic mechanisms, limited diagnostic tools, and lack of proven targeted therapy.
Namrita D. Ashokprabhu, Odayme Quesada, Yulith Roca Alvarez, Timothy D. Henry   +3 more
doaj   +1 more source

Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction [PDF]

Reviews in Cardiovascular Medicine, 2021
Heart failure with preserved ejection fraction (HFpEF) is one of the greatest unmet needs in modern medicine. The lack of an appropriate therapy may reflect the lack of an accurate comprehension of its pathophysiology.
Francesco Tona, Roberta Montisci, Laura Iop, Giovanni Civieri   +3 more
doaj   +1 more source

Vascular Remodeling in Coronary Microvascular Dysfunction.

JACC: Cardiovascular Imaging
Approximately one-half of the patients with angina and nonobstructive coronary artery disease (ANOCA) have evidence of coronary microvascular dysfunction (CMD).
Buytaert, D., Brouwers, S., Sakai, K., Caglioni, S., Storozhenko, T., Seki, R., Bartunek, J., Mizukami, T., van Hoe, L., Collet, C., Ohashi, H., Vanderheyden, M., Bouisset, F., Wyffels, E., Bertolone, D.T., Gallinoro, E., Munhoz, D., Sonck, J., Pardaens, S., Tajima, A., De Bruyne, B.   +20 more
core   +4 more sources

Coronary Microvascular Dysfunction

Journal of the Society for Cardiovascular Angiography & Interventions
Coronary microvascular dysfunction (CMD) is a key mechanism underlying ischemic heart disease (IHD), yet its diagnosis and treatment remain challenging. This article presents a comprehensive overview of CMD research, covering its pathogenesis, diagnostic criteria, assessment techniques, risk factors, and therapeutic strategies.
Yader Sandoval, Joaquin E. Cigarroa, George D. Dangas, Alexandra J. Lansky, Srihari S. Naidu, Sunil V. Rao, Arnold H. Seto, Samit Shah, Adhir R. Shroff, Olga Toleva, Jennifer A. Tremmel, Robert F. Riley, Timothy D. Henry, Connie S. Baumgard, Ilka Bijoux, Lisa Cavaliere, Casey Culbertson, Regina Deible, Maya El-Sabban, Jeremy Jackson, Melissa Jackson, Bethany Kalich, Vanessa Long, Amy Newell, Daya Perkins, Krish Ramakrishnan, Karen Russell, Vinod Sharma, Nick E.J. West, Chrissy Whalen-Morton, Paul Underwood, Kristi Winterfeldt, Cezary Wojcik, Steve Zizzo   +33 more
  +9 more sources

Paradoxical coronary vasospasm and transient apical ballooning in a post-menopausal woman: An imaging case report of an unusual INOCA presentation

American Heart Journal Plus, 2022
Ischemia with non-obstructive coronary artery disease (INOCA), a common cause of angina, can occur due to coronary vasospasm, microvascular dysfunction, endothelial dysfunction, atherosclerosis or a combination of these mechanisms.
Madhavi Kadiyala, Saikrishna Patibandla, Erin D. Michos   +2 more
doaj   +1 more source

A review of cardio-pulmonary microvascular dysfunction in pulmonary hypertension

American Heart Journal Plus, 2023
Microvascular dysfunction progressing to pulmonary hypertension can be a primary cause of right ventricular failure or a secondary cause because of an underlying systemic illness.
Cyrus Vahdatpour, Samuel Epstein, Kirk Jones, Madeline Smoot, Alex Parker, John Ryan, Andrew Bryant   +6 more
doaj   +1 more source

Coronary Microvascular Dysfunction

Journal of the American College of Cardiology, 2018
-
Paolo G. Camici 1, Ornella E. Rimoldi 1, Filippo Crea 3   +2 more
  +5 more sources

Coronary endothelial dysfunction appears to be a manifestation of a systemic process: A report from the Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction (WISE-CVD) study.

PLoS ONE, 2021
BackgroundCoronary microvascular dysfunction (CMD) is prevalent in symptomatic women with ischemia but no obstructive coronary artery disease (INOCA). Urine albumin-creatinine ratio (UACR) is a measure of renal microvascular endothelial dysfunction. Both
Sawan Jalnapurkar, Sofy Landes, Janet Wei, Puja K Mehta, Chrisandra Shufelt, Margo Minissian, Carl J Pepine, Eileen Handberg, Galen Cook-Wiens, George Sopko, C Noel Bairey Merz   +10 more
doaj   +1 more source

Treatment of coronary microvascular dysfunction [PDF]

Cardiovascular Research, 2020
Abstract Contemporary data indicate that patients with signs and symptoms of ischaemia and non-obstructive coronary artery disease (INOCA) often have coronary microvascular dysfunction (CMD) with elevated risk for adverse outcomes. Coronary endothelial (constriction with acetylcholine) and/or microvascular (limited coronary flow reserve ...
Colin Berry, Hiroki Shimokawa, Carl J Pepine, C Noel Bairey Merz   +3 more
openaire   +2 more sources